Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBSSL added to infant formula versus placebo in preterm infants
2007-002423-33Phase 2Completed
- Sponsor
- Sobi
- Start
- Oct 2007
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bucelipase alfa in fat malabsorption and lipid metabolism disorder (2 arms), sponsored by Sobi. Primary endpoint: Coefficient of fat absorption. Started Oct 2007; status: completed.
02
Drugs
bucelipase alfa
03
Conditions
fat malabsorptionlipid metabolism disorder
Beyond the preview
Go deeper on 2007-002423-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002423-33.